SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001169232-03-002572
Filing Date
2003-03-31
Accepted
2003-03-31 14:51:58
Documents
14
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d54920_10k.txt 10-K 277498
3 WARRANT NO. 5 d54920_ex4-5.txt EX-4.5 19913
4 WARRANT NO.6 d54920_ex4-6.txt EX-4.6 19901
5 WARRANT NO. 7 d54920_ex4-7.txt EX-4.7 19827
6 WARRANT NO. 8 d54920_ex4-8.txt EX-4.8 19834
7 WARRANT NO. 9 d54920_ex4-9.txt EX-4.9 19834
8 WARRANT NO. 10 d54920_ex4-10.txt EX-4.10 19851
9 WARRANT NO. 11 d54920_ex4-11.txt EX-4.11 19873
10 SEVERANCE AGREEMENT d54920_ex10-1.txt EX-10.1 28819
11 SEVERANCE AGREEMENT d54920_ex10-2.txt EX-10.2 26354
12 AMENDMENT TO LICENSE AGREEMENT d54920_ex10-18.txt EX-10.18 2333
13 LIST OF SUBSIDIARIES d54920_ex21-1.txt EX-21.1 267
14 CONSENT OF KPMG d54920_ex23-1.txt EX-23.1 940
15 CERTIFICATION d54920_ex99-1.txt EX-99.1 2470
  Complete submission text file 0001169232-03-002572.txt   480674
Mailing Address
Business Address 216 JAFFA ROAD SHAAREI HAIR JERUSALEM ISRAEL 94383 9722534997
KERYX BIOPHARMACEUTICALS INC (Filer) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30929 | Film No.: 03629469
SIC: 2834 Pharmaceutical Preparations